BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gendy AM, Amin MM, Al-Mokaddem AK, Abd Ellah MF. Cilostazol mitigates mesenteric ischemia/reperfusion-induced lung lesion: Contribution of PPAR-γ, NF-κB, and STAT3 crosstalk. Life Sci 2021;266:118882. [PMID: 33310046 DOI: 10.1016/j.lfs.2020.118882] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Osman AT, Sharkawi SMZ, Hassan MIA, Abo-Youssef AM, Hemeida RAM. Empagliflozin and neohesperidin protect against methotrexate-induced renal toxicity via suppression of oxidative stress and inflammation in male rats. Food Chem Toxicol 2021;155:112406. [PMID: 34256053 DOI: 10.1016/j.fct.2021.112406] [Reference Citation Analysis]
2 Kherallah RY, Khawaja M, Olson M, Angiolillo D, Birnbaum Y. Cilostazol: a Review of Basic Mechanisms and Clinical Uses. Cardiovasc Drugs Ther 2021. [PMID: 33860901 DOI: 10.1007/s10557-021-07187-x] [Reference Citation Analysis]
3 Refaie MMM, El-Hussieny M, Shehata S. TLR4/NF-κB/TNFα and cAMP/SIRT1 signaling cascade involved in mediating the dose-dependent effect of cilostazol in ovarian ischemia reperfusion-induced injury. Immunopharmacol Immunotoxicol 2022;:1-9. [PMID: 35209787 DOI: 10.1080/08923973.2022.2043901] [Reference Citation Analysis]
4 Huang R, Zhang C, Wang X, Hu H. PPARγ in Ischemia-Reperfusion Injury: Overview of the Biology and Therapy. Front Pharmacol 2021;12:600618. [PMID: 33995008 DOI: 10.3389/fphar.2021.600618] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhang Y, Zhang Y, Li Y, Zhang L, Yu S. Preclinical Investigation of Alpinetin in the Treatment of Cancer-Induced Cachexia via Activating PPARγ. Front Pharmacol 2021;12:687491. [PMID: 34093209 DOI: 10.3389/fphar.2021.687491] [Reference Citation Analysis]